Skip to content

Clinical trials

Hemorrhage trials in Switzerland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemorrhage Country / region: Switzerland Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20071
20083
20091
20111
20125
20131
20141
20151
20171
20181
20192
20206
20211
20222
20232
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting4
Terminated4
Unknown status3
Active, not recruiting2
Withdrawn2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital, Basel, Switzerland5
University of Zurich4
Biosensors Europe SA2
Christian Haslinger2
Idorsia Pharmaceuticals Ltd.2
Insel Gruppe AG, University Hospital Bern2
Sangart2
University Hospital, Geneva2
Abbott Medical Devices1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemorrhage35
Blood Loss, Surgical4
Stroke4
Atrial Fibrillation3
Hemostatic Disorders3
Shock, Hemorrhagic3
Wounds and Injuries3
Acidosis, Lactic2
Aortic Valve Stenosis2
Myocardial Infarction2

Trials

Showing 76 to 35 of 35. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.